International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-2 doi: 10.5281/zenodo.7786477
Original Article
Risk Factors of Severe Dengue Infection in Paediatric Patients-A Single Centre Prospective Study
 ,
Published
March 30, 2023
Abstract
Introduction: Dengue epidemics are known to have occurred over the last three centuries in tropical, subtropical and temperate areas of the world. Dengue creates a huge burden on public health world-wide. Severe dengue can lead to more lethal condition. Hence early recognition of severe cases is important for management of paediatric dengue patients. Objective: To assess the risk factors of severe dengue infection in paediatric patients. Methods: A hospital-based prospective study was conducted at from June 2022 to November 2022 Bangladesh Shishu Hospital & Institute, Dhaka, Bangladesh. Seventy two (72) patients included in the study. In children with high degree clinical suspicion of dengue infection NS 1 antigen (who came within first 72 hours of fever) and/or dengue antibody IgM, IgG (who came after five days of fever) were performed. Positive dengue cases were taken written informed consent & interviewed on the risk factors of dengue infection. Data related to patient’s demography, risk factors, clinical presentation, pattern of dengue infection and outcome were documented on the pre-structured questionnaire. Results: Total of 72 patients with dengue infection met the inclusion criteria, in which 29 and 43 were diagnosed as severe dengue and non-severe dengue infection, respectively. All patients were confirmed by serologic marker (NS-1 or IgM/ IgG Dengue). All subjects were carried out anamnesis, physical examination, and laboratory. Clinical and laboratory examination (complete blood count, AST, ALT, albumin, APTT, S. ferritin and d-dimer) were analysis comparing non-severe dengue and severe dengue patients. Characteristics of 72 research subjects can be seen. On bivariate analysis, there were significant differences of nutritional status, abdominal pain, vomiting, petechiae, hepatomegaly, pleural effusion, leukopenia, thrombocytopenia, hypoalbuminemia, increasing AST > 3x, elevated D- dimer, hyperferritinemia and prolonged APTT between severe and non-severe dengue group. After multivariate analysis, the prognostic factors of severe dengue were overweight/obesity (p=0.003, RR 94), vomiting (p=0.02, RR 13.3), hepatomegaly (p=0.01, RR=69.4), hyperferritinemia (p=0.01, RR=15.4) and prolonged APTT (p=0.005, RR=43.25). In overweight/obesity, vomiting, hepatomegaly, and hyperferritinemia prolonged APTT were prognostic factors in severe dengue infection in children. Conclusion: In conclusion, overweight/obesity, vomiting, hepatomegaly, and hyperferritinemia prolonged APTT were prognostic factors in severe dengue infection in children. Considering these factors for awareness of severe dengue in patients with dengue virus infection. Clinicians should emphasize the monitoring of these factors for early detection of serious dengue state.
Recommended Articles
Loading Image...
Volume-4, Issue-2
Citations
2473 Views
445 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved